APA (7th ed.) Citation

Zannettino, A. C., Farrugia, A. N., Kortesidis, A., Manavis, J., To, L. B., Martin, S. K., . . . Gronthos, S. (2005). Elevated Serum Levels of Stromal-Derived Factor-1α Are Associated with Increased Osteoclast Activity and Osteolytic Bone Disease in Multiple Myeloma Patients. Cancer research (Chicago, Ill.), 65(5), 1700-1709. https://doi.org/10.1158/0008-5472.CAN-04-1687

Chicago Style (17th ed.) Citation

Zannettino, Andrew C.W., et al. "Elevated Serum Levels of Stromal-Derived Factor-1α Are Associated with Increased Osteoclast Activity and Osteolytic Bone Disease in Multiple Myeloma Patients." Cancer Research (Chicago, Ill.) 65, no. 5 (2005): 1700-1709. https://doi.org/10.1158/0008-5472.CAN-04-1687.

MLA (9th ed.) Citation

Zannettino, Andrew C.W., et al. "Elevated Serum Levels of Stromal-Derived Factor-1α Are Associated with Increased Osteoclast Activity and Osteolytic Bone Disease in Multiple Myeloma Patients." Cancer Research (Chicago, Ill.), vol. 65, no. 5, 2005, pp. 1700-1709, https://doi.org/10.1158/0008-5472.CAN-04-1687.